AWM Investment Company, Inc. - Oct 1, 2021 Form 4 Insider Report for INVO Bioscience, Inc. (INVO)

Role
10%+ Owner
Signature
Adam Stettner
Stock symbol
INVO
Transactions as of
Oct 1, 2021
Transactions value $
$0
Form type
4
Date filed
10/12/2021, 04:50 PM
Previous filing
Oct 5, 2021
Next filing
Nov 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding INVO Common Stock 1.16M Oct 1, 2021 By Limited Partnerships F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

AWM Investment Company, Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 AWM Investment Company, Inc., a Delaware Corporation (AWM), is the investment adviser to Special Situations Fund III QP, L.P. (QP), Special Situations Cayman Fund, L.P. (Cay) and Special Situations Life Sciences Fund, L.P. (LS). (LS and together with QP and Cay, the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 400,559 shares of Common Stock of the Issuer (the Shares) held by QP, 133,516 Shares held by Cay and 625,000 Shares held by LS.Austin W. Marxe (Marxe), David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are the controlling principals of AWM. The reporting person disclaims beneficial ownership of the Shares, except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F2 As a result of a change in shares outstanding, AWM Investment Company Inc. beneficially owns less than 10%. No additional filings are required at this time.